. Author manuscript; available in PMC: 2020 Jun 3.

Published in final edited form as: Drugs Aging. 2019 Jun;36(6):549–557. doi: 10.1007/s40266-019-00650-3

Table 2.

Types of adjuvant use at admission among nursing home residents with cancer (N=556).

Use of adjuvant analgesic agents^§	No. (%) using the drug
Anticonvulsants
Pregabalin	38 (6.8)
Gabapentin	191 (34.4)
Carbamazepine	10 (1.8)
Lamotrigine	8 (1.4)
Antidepressants
Amitriptyline	17 (3.1)
Nortriptyline	3 (0.5)
Desipramine	1 (0.2)
Imipramine	6 (1.1)
Duloxetine	67 (12.1)
Venlafaxine	38 (6.8)
Corticosteroid^¶	163 (29.3)
Topical agents: Lidocaine	100 (18.0)

^§

Residents could have more than one adjuvant. Overall, 14.2% of residents with cancer who used opioids during the admission period had more than one adjuvant.

^¶

Systematic corticosteroids including prednisone, dexamethasone, betamethasone, hydrocortisone etc.